Data / Research funding / Uterine Cancer

Uterine Cancer: 84 NIH awards ($101M) to 48 organizations

Name: NIH and NSF awards on Uterine Cancer
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

84 NIH awards ($101M) in the NIH spending category Uterine Cancer, to 48 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Get awards on Uterine Cancer Watch Uterine Cancer

Topic: NIH spending category

Awards

84 awards in the window.

Award	Agency	Institute or division	Fiscal year	Amount in window	Start	End	Principal investigator	Source
Nebraska Center for Molecular Target Discovery and Development	NIH	National Institute of General Medical Sciences	2021 to 2025	$12,120,081	March 16, 2018	June 30, 2028	LEWIS, ROBERT E.	reporter.nih.gov
Washington University/Siteman Cancer Center Lead Academic Site	NIH	National Cancer Institute	2021 to 2025	$6,572,668	March 5, 2019	February 28, 2026	BARTLETT, NANCY L	reporter.nih.gov
Detroit Research on Cancer Survivors (Detroit ROCS)	NIH	National Cancer Institute	2021 to 2025	$6,266,318	February 27, 2017	February 28, 2027	SCHWARTZ, ANN G.	reporter.nih.gov
Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities	NIH	National Cancer Institute	2021 to 2025	$4,544,010	February 5, 2021	January 31, 2027	DE VIVO, IMMACULATA	reporter.nih.gov
Comparative Modeling for the Prevention and Control of Uterine Cancer	NIH	National Cancer Institute	2021 to 2025	$4,171,414	September 17, 2021	August 31, 2026	WRIGHT, JASON	reporter.nih.gov
Training of Academic Gynecologic Oncologists	NIH	National Cancer Institute	2021 to 2025	$2,684,417	September 15, 2005	June 30, 2026	SOOD, ANIL K	reporter.nih.gov
Systematic Characterization and Targeting of Neomorphic Drivers in Cancer	NIH	National Cancer Institute	2023 to 2025	$2,554,135	September 19, 2023	August 31, 2028	MILLS, GORDON B.	reporter.nih.gov
Life history of the menstruating uterus	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2022 to 2025	$2,527,271	September 20, 2022	August 31, 2027	MCKINLEY, KARA LAVIDGE	reporter.nih.gov
HER2-mediated delivery of cytotoxic agents in solid tumors	NIH	National Cancer Institute	2021 to 2024	$2,298,246	April 1, 2021	March 31, 2025	CHANDARLAPATY, SARAT	reporter.nih.gov
PAI-1-mediated early-onset endometrial cancer	NIH	National Cancer Institute	2021 to 2025	$2,148,818	June 1, 2021	May 31, 2027	KIRMA, NAMEER	reporter.nih.gov
Endometrial epithelial stem cells and cancer	NIH	National Cancer Institute	2021 to 2025	$2,130,125	June 1, 2021	May 31, 2027	NIKITIN, ALEXANDER Y.	reporter.nih.gov
Elucidation of Human Natural Killer Cell Development	NIH	National Cancer Institute	2021 to 2025	$2,036,594	May 1, 2023	April 30, 2028	FREUD, AHARON G	reporter.nih.gov
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer	NIH	National Cancer Institute	2022 to 2025	$1,940,870	September 23, 2022	January 31, 2027	JEONG, JAE-WOOK	reporter.nih.gov
Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors	NIH	National Cancer Institute	2023 to 2025	$1,811,537	February 1, 2019	January 31, 2026	PHILLIPS, SIOBHAN MARIE	reporter.nih.gov
Understanding multilevel drivers of gaps in guideline-concordant endometrial cancer treatment in high-risk populations	NIH	National Cancer Institute	2022 to 2025	$1,808,695	July 1, 2022	November 30, 2025	FELIX, ASHLEY S.	reporter.nih.gov
Development of new therapeutic approaches for endometrial cancer	NIH	National Cancer Institute	2022 to 2025	$1,747,994	August 22, 2022	July 31, 2027	VISWANADHAPALLI, SURYAVATHI	reporter.nih.gov
Restoring Progestin Sensitivity in Endometrial Cancer	NIH	National Cancer Institute	2021 to 2025	$1,733,812	June 1, 2019	May 31, 2026	YANG, SHUJIE	reporter.nih.gov
Development of Claudin MAbs for Treating Solid Tumors	NIH	National Cancer Institute	2022 to 2024	$1,703,866	June 1, 2022	November 30, 2024	RUCKER, JOSEPH BENJAMIN	reporter.nih.gov
Functional characterization of mesenchymal-epithelial transition (MET)-derived cells in normal endometrial regeneration	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021 to 2025	$1,624,599	May 15, 2021	April 30, 2027	PATTERSON, AMANDA	reporter.nih.gov
Regulation of endometrial proliferation by the PGRMC family	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021 to 2025	$1,622,375	April 15, 2021	March 31, 2027	PRU, JAMES K	reporter.nih.gov
The NYU Women's Health Study	NIH	National Cancer Institute	2021 to 2023	$1,621,115	May 1, 2015	April 30, 2025	CHEN, YU	reporter.nih.gov
Role of semaglutide in restoring ovulation in youth and adults with polycystic ovary syndrome	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023 to 2025	$1,596,199	August 15, 2023	July 31, 2028	CREE, MELANIE G	reporter.nih.gov
Understanding Progesterone Receptor action in Obesity for Endometrial Cancer Prevention	NIH	National Cancer Institute	2021 to 2024	$1,565,459	July 1, 2019	June 30, 2026	KIM, JI-YONG JULIE	reporter.nih.gov
Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors	NIH	National Cancer Institute	2021 to 2022	$1,417,029	February 1, 2019	January 31, 2024	CADMUSBERTRAM, LISA ANNE	reporter.nih.gov
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer	NIH	National Cancer Institute	2021 to 2024	$1,397,926	March 14, 2018	February 28, 2026	BAE-JUMP, VICTORIA LIN	reporter.nih.gov
Understanding endometrial tissue field defects in obesity-related endometrial hyperplasia	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2025	$1,394,304	September 1, 2025	August 31, 2027	CHANDLER, RONALD L	reporter.nih.gov
Unravelling mechanisms and novel therapeutic targets for progesterone-resistant endometrial hyperplasia	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023 to 2025	$1,372,096	August 4, 2023	May 31, 2028	KIM, TAE HOON	reporter.nih.gov
Obesity-driven endometrial hyperplasia in postmenopausal women: Synergistic role for insulin and estrone	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021 to 2023	$1,344,350	February 1, 2019	January 31, 2026	FLANNERY, CLARE ANN	reporter.nih.gov
Mechanisms Governing Uterine Epithelial Plasticity	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023 to 2025	$1,317,825	August 3, 2023	May 31, 2028	KELLEHER, ANDREW M	reporter.nih.gov
The Carolina Endometrial Cancer Study: A population-based survivor cohort	NIH	National Cancer Institute	2024 to 2025	$1,296,980	March 1, 2024	February 28, 2029	NICHOLS, HAZEL B	reporter.nih.gov
PCOS and androgen-related disease modeling and drug testing in Multi-organ Integrated Microfluidic Reproductive Platform	NIH	National Institute of Environmental Health Sciences	2021	$1,261,686	September 15, 2019	August 31, 2023	KIM, JI-YONG JULIE	reporter.nih.gov
Racial Disparity in Diagnostic Evaluation of Uterine Cancer	NIH	National Institute on Minority Health and Health Disparities	2021 to 2023	$1,248,175	August 27, 2021	September 29, 2023	XU, XIAO	reporter.nih.gov
Botanical derived progestins and their impact on women's health	NIH	National Center for Complementary & Integrative Health	2023 to 2025	$1,151,280	May 1, 2016	February 29, 2028	BURDETTE, JOANNA E	reporter.nih.gov
Combination Therapies Targeting Insulin Signaling in Endometrial Cancer	NIH	National Cancer Institute	2024 to 2025	$1,035,009	August 1, 2024	July 31, 2028	GONCALVES, MARCUS DASILVA	reporter.nih.gov
Infertility and Long-Term Health Outcomes Among Hispanic Women with Mexican Heritage	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2024 to 2025	$956,660	August 22, 2024	June 30, 2029	FARLAND, LESLIE V	reporter.nih.gov
Combined NGS tumor-based detection of germline Lynch syndrome mutations and prognostic classification of endometrial cancers	NIH	National Cancer Institute	2021 to 2022	$925,110	July 6, 2018	June 30, 2024	GOODFELLOW, PAUL JOSEPH	reporter.nih.gov
The combined role of ARID1A loss and estrogen signaling in endometrial cancer	NIH	National Cancer Institute	2024 to 2025	$844,507	March 4, 2024	February 28, 2029	GERTZ, JASON	reporter.nih.gov
Improving sleep in gynecologic cancer survivors	NIH	National Cancer Institute	2022 to 2025	$749,336	February 1, 2021	January 31, 2026	FOX, RINA S	reporter.nih.gov
Does obesity influence protein quality control in endometrial cancer?	NIH	National Cancer Institute	2023 to 2025	$747,000	April 1, 2021	November 30, 2025	WILSON, MICHAEL R	reporter.nih.gov
Targeted Therapy for Endometrial Cancer	NIH	National Cancer Institute	2021 to 2023	$683,180	July 1, 2002	April 30, 2025	LESLIE, KIMBERLY K.	reporter.nih.gov
Unraveling heterogeneity in endometrial cancer via integrated single cell genotype-phenotype mapping	NIH	National Cancer Institute	2025	$642,732	August 1, 2025	July 31, 2030	HOWITT, BROOKE E	reporter.nih.gov
Racial Disparity in Diagnostic Evaluation of Uterine Cancer	NIH	National Institute on Minority Health and Health Disparities	2023 to 2024	$569,643	August 27, 2021	March 14, 2025	XU, XIAO	reporter.nih.gov
Attacking aggressive p53 mutants in gynecologic cancer	NIH	National Cancer Institute	2022 to 2024	$560,520	August 1, 2022	July 31, 2025	THIEL, KRISTINA W	reporter.nih.gov
Mechanisms and Consequences of PAX2 Inactivation in the Initiation of Endometrial Carcinogenesis	NIH	National Cancer Institute	2025	$551,975	December 2, 2024	November 30, 2029	CASTRILLON, DIEGO H	reporter.nih.gov
Combination Therapies Targeting Insulin Signaling in Endometrial Cancer	NIH	National Cancer Institute	2023 to 2024	$551,433	April 1, 2023	May 31, 2024	GONCALVES, MARCUS DASILVA	reporter.nih.gov
Increasing access to cancer trials in Minnesota (InACT-MN)	NIH	National Cancer Institute	2023 to 2025	$548,508	September 18, 2023	August 31, 2028	ERICKSON, BRITT KRISTINA	reporter.nih.gov
Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer	NIH	National Cancer Institute	2021 to 2022	$478,385	September 18, 2018	August 31, 2024	RAUH-HAIN, JOSE ALEJANDRO	reporter.nih.gov
Development of integrated risk models of genetic and non-genetic risk factors in endometrial cancer across diverse ancestries	NIH	National Cancer Institute	2024	$456,103	September 2, 2024	August 31, 2026	CHAMBWE, NYASHA	reporter.nih.gov
Development of bifunctional CDK2 inhibitors for treatment of CCNE1-driven cancers	NIH	National Cancer Institute	2024 to 2025	$433,255	April 1, 2024	March 31, 2026	SCHONBRUNN, ERNST	reporter.nih.gov
Dissecting the role of RPLP1 in female reproductive tract pathologies	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2022 to 2023	$426,250	September 15, 2022	August 31, 2025	NOTHNICK, WARREN B	reporter.nih.gov
A novel uterine leiomyosarcoma mouse model for therapeutic development	NIH	National Cancer Institute	2024 to 2025	$416,543	January 11, 2024	June 30, 2026	WONG, KWONG KWOK	reporter.nih.gov
Targeting poly (ADP ribose) polymerase (PARP) in endometrial cancer	NIH	National Cancer Institute	2022 to 2023	$405,113	December 1, 2021	November 30, 2024	WEROHA, SARAVUT	reporter.nih.gov
Patient Navigation in Gynecologic Oncology: Improving Care among Rural Endometrial Cancer Patients	NIH	National Institute on Minority Health and Health Disparities	2022 to 2025	$404,489	September 25, 2022	December 31, 2026	SPEES, LISA PATTERSON	reporter.nih.gov
Development of a biomarker panel for screening and early detection of gynecological cancers	NIH	National Cancer Institute	2021	$399,972	September 1, 2021	August 31, 2023	MARTIGNETTI, JOHN A	reporter.nih.gov
Impact of Obesity on Immuno-Oncology Agents in Endometrial Cancer	NIH	National Cancer Institute	2022 to 2024	$390,742	August 1, 2022	July 31, 2025	BAE-JUMP, VICTORIA LIN	reporter.nih.gov
Biologic rationale of fallopian tube removal to prevent uterine serous carcinoma	NIH	National Cancer Institute	2025	$388,256	September 1, 2025	August 31, 2027	DELANEY, JOE R	reporter.nih.gov
Mechanisms of tamoxifen-associated endometrial cancer risk	NIH	National Cancer Institute	2023 to 2024	$386,857	May 1, 2023	April 30, 2026	GERTZ, JASON	reporter.nih.gov
Signature-guided therapy for mismatch repair defective cancers	NIH	National Cancer Institute	2021	$373,331	August 1, 2017	July 31, 2023	LIN, SHIAW-YIH	reporter.nih.gov
Phase I trial of intravenous vesicular stomatitis virus for treatment of metastatic endometrial cancer	NIH	National Cancer Institute	2021	$373,073	May 4, 2017	August 31, 2023	BAKKUM-GAMEZ, JAMIE N	reporter.nih.gov
Promoting gynecologic cancer patients with frailty to achieve functional recovery cohort study (PROOF Cohort Study)	NIH	National Institute on Aging	2024	$349,561	September 1, 2024	August 31, 2026	CHAM, STEPHANIE	reporter.nih.gov
Development of lavage EV protein biomarkers for minimally-invasive detection of endometrial cancer	NIH	National Cancer Institute	2022	$290,000	September 1, 2022	August 31, 2024	ILIUK, ANTON	reporter.nih.gov
NCOA6, A Novel Tumor Suppressor of Endometrial Cancer	NIH	National Cancer Institute	2021	$287,519	December 1, 2015	November 30, 2023	XU, JIANMING	reporter.nih.gov
Enhancing accrual across gynecologic and solid tumor trials	NIH	National Cancer Institute	2024 to 2025	$271,146	September 1, 2024	August 31, 2029	DUSKA, LINDA	reporter.nih.gov
Effect of adiposity changes on endometrial tissue and blood biomarkers in women at increased risk for endometrial cancer	NIH	National Cancer Institute	2021 to 2022	$267,250	April 1, 2018	March 31, 2023	FELIX, ASHLEY S.	reporter.nih.gov
Gynecologic cancer care: Improving clinical trial enrollment through molecular matching with targeted therapies and improving access to care and research	NIH	National Cancer Institute	2024 to 2025	$264,030	September 11, 2024	August 31, 2029	BACKES, FLOOR J.	reporter.nih.gov
Molecular Mechanisms Underlying Environmental Effects that Influence Penetrance in Lynch Syndrome-Associated Endometrial Cancer	NIH	National Cancer Institute	2021	$256,000	April 5, 2017	February 28, 2024	YATES, MELINDA S.	reporter.nih.gov
The role of cholesterol biosynthesis in metastatic and recurrent endometrial cancer	NIH	National Cancer Institute	2022	$254,927	February 2, 2022	August 31, 2022	JEONG, JAE-WOOK	reporter.nih.gov
Does obesity influence protein quality control in endometrial cancer?	NIH	National Cancer Institute	2021 to 2022	$236,888	April 1, 2021	November 30, 2022	WILSON, MICHAEL R	reporter.nih.gov
Overcoming treatment-resistant gynecological cancers by combination of DNA damage response inhibitors	NIH	National Cancer Institute	2024 to 2025	$224,104	September 12, 2024	August 31, 2029	XU, HAINENG	reporter.nih.gov
Investigation of socio-genomic associations related to survivial among a population-based sample of those diagnosed with endometrial cancer in Metropolitan Detroit	NIH	National Cancer Institute	2025	$183,309	August 1, 2025	July 31, 2030	GOTTSCHLICH, ANNA P	reporter.nih.gov
Targeted Therapy for Endometrial Cancer	NIH	National Cancer Institute	2021	$178,025	July 1, 2002	December 31, 2021	LESLIE, KIMBERLY K.	reporter.nih.gov
Claims-based measures of care coordination and long-term health among older women with endometrial cancer	NIH	National Cancer Institute	2023 to 2024	$155,500	January 19, 2023	December 31, 2024	ANDERSON, CHELSEA	reporter.nih.gov
Infertility and Risk of Breast, Gynecologic, and Colorectal Cancer	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2021 to 2022	$153,500	April 1, 2021	March 31, 2024	FARLAND, LESLIE V	reporter.nih.gov
TET2 as a novel epigenetic regulator for uterine function and fertility	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2023	$152,000	August 8, 2023	July 31, 2025	WANG, XIAOQIU	reporter.nih.gov
Combination Of Autophagy Selective Therapeutics (COAST) in Serous Ovarian Cancer	NIH	National Cancer Institute	2022 to 2023	$150,854	December 1, 2021	November 30, 2023	DELANEY, JOE R	reporter.nih.gov
Developing and Validating Prognostic Models for Black women with Endometrial Cancer following Hysterectomy	NIH	National Cancer Institute	2025	$132,825	February 13, 2025	January 31, 2027	PEERI, NOAH CHARLES	reporter.nih.gov
Inflammation and gynecologic cancer: the role of prostaglandins in ovarian cancer	NIH	National Cancer Institute	2021	$114,180	July 18, 2018	June 30, 2022	BARNARD, MOLLIE ELYSE	reporter.nih.gov
Integrative Approach to Understand the Role of Diet, Physical Activity and Adiposity on Survival in Patients with Colorectal, Endometrial and Prostate Cancer	NIH	National Cancer Institute	2021	$82,818	May 15, 2020	April 30, 2022	LEE, DONGHOON	reporter.nih.gov
Endometrial Cancer Survival and Survivorship among Latinas in California: A Mixed Methods Study	NIH	National Cancer Institute	2022 to 2024	$74,186	January 2, 2023	August 5, 2024	RODRIGUEZ, VICTORIA ELIZABETH	reporter.nih.gov
Deciphering the functional role of recurrent PPP2R1A mutations on endometrial metastasis	NIH	National Cancer Institute	2023 to 2024	$59,365	September 1, 2023	November 30, 2024	HAANEN, TERRANCE JAMES	reporter.nih.gov
Deciphering the Functional Role of PPP2R1A Mutations in Cancer	NIH	National Cancer Institute	2025	$43,109	June 1, 2025	May 31, 2027	HAROLD, ALEXIS CATHERINE	reporter.nih.gov
Obesity-induced endometrial stromal cell fibrosis and immunosuppression leads to increased endometrial hyperplasia disease severity	NIH	Eunice Kennedy Shriver National Institute of Child Health & Human Development	2025	$42,751	May 16, 2025	May 15, 2028	SKALSKI, HILARY	reporter.nih.gov
Diurnal Variations in Salivary Concentrations of Pro-Tumorigenic Cytokines and Possible Effects of Psycho-Physiological Stress in Gynecologic Cancer Patients and Matched Healthy Controls	NIH	National Cancer Institute	2021	$41,244	December 1, 2019	November 30, 2021	PADRON, ADAIXA	reporter.nih.gov
Approaches to Curtail Endometrial Cancer Incidence and Mortality	NIH	National Cancer Institute	2023	$27,000	July 1, 2020	April 30, 2023	DU, MENGMENG	reporter.nih.gov

Organizations

Organization	Place	NIH awards	NIH amount	NSF amount
University of Nebraska Medical Center	Omaha, NE	1	$12.1 million	$0
Wayne State University	Detroit, MI	3	$7.2 million	$0
Washington University	Saint Louis, MO	1	$6.6 million	$0
University of Missouri-Columbia	Columbia, MO	4	$6.3 million	$0
Ohio State University	Columbus, OH	5	$5.3 million	$0
Columbia University Health Sciences	New York, NY	2	$4.7 million	$0
Northwestern University at Chicago	Chicago, IL	3	$4.6 million	$0
Brigham and Women's Hospital	Boston, MA	1	$4.5 million	$0
University of TX MD Anderson Can CTR	Houston, TX	5	$4.2 million	$0
University of Texas HLTH Science Center	San Antonio, TX	2	$3.9 million	$0
Univ of North Carolina Chapel Hill	Chapel Hill, NC	5	$3.6 million	$0
New York University School of Medicine	New York, NY	2	$2.7 million	$0
Yale University	New Haven, CT	2	$2.6 million	$0
Oregon Health & Science University	Portland, OR	1	$2.6 million	$0
Harvard University	Cambridge, MA	1	$2.5 million	$0
University of Iowa	Iowa City, IA	3	$2.5 million	$0
Sloan-Kettering Inst Can Research	New York, NY	3	$2.5 million	$0
Cornell University	Ithaca, NY	1	$2.1 million	$0
University of Arizona	Tucson, AZ	3	$1.9 million	$0
Integral Molecular	Philadelphia, PA	1	$1.7 million	$0
University of Wyoming	Laramie, WY	1	$1.6 million	$0
University of Colorado Denver	Aurora, CO	1	$1.6 million	$0
Henry Ford Health + Michigan State University Health Sciences	East Lansing, MI	2	$1.4 million	$0
University of Wisconsin-Madison	Madison, WI	1	$1.4 million	$0
University of Utah	Salt Lake City, UT	3	$1.3 million	$0
University of Illinois at Chicago	Chicago, IL	1	$1.2 million	$0
Mayo Clinic Rochester	Rochester, MN	2	$778,186	$0
University of New Mexico Health Scis CTR	Albuquerque, NM	1	$683,180	$0
Stanford University	Stanford, CA	1	$642,732	$0
Ut Southwestern Medical Center	Dallas, TX	1	$551,975	$0
Weill Medical Coll of Cornell Univ	New York, NY	1	$551,433	$0
University of Minnesota	Minneapolis, MN	1	$548,508	$0
Medical University of South Carolina	Charleston, SC	2	$539,110	$0
Michigan State University	East Lansing, MI	2	$491,815	$0
Feinstein Institute for Medical Research	Manhasset, NY	1	$456,103	$0
H. Lee Moffitt Cancer CTR & Res Inst	Tampa, FL	1	$433,255	$0
University of Kansas Medical Center	Kansas City, KS	1	$426,250	$0
MDDX, Inc.	New York, NY	1	$399,972	$0
University of California, San Francisco	San Francisco, CA	1	$349,561	$0
Tymora Analytical Operations, LLC	West Lafayette, IN	1	$290,000	$0
Baylor College of Medicine	Houston, TX	1	$287,519	$0
University of Virginia	Charlottesville, VA	1	$271,146	$0
University of Pennsylvania	Philadelphia, PA	1	$224,104	$0
North Carolina State University	Raleigh, NC	1	$152,000	$0
University of Michigan at Ann Arbor	Ann Arbor, MI	2	$102,474	$0
Harvard University D/b/a Harvard School of Public Health	Boston, MA	1	$82,818	$0
University of California-Irvine	Irvine, CA	1	$74,186	$0
University of Florida	Gainesville, FL	1	$41,244	$0

Funding by fiscal year

Fiscal year	NIH awards	NIH amount	NSF amount
2025	43	$22,157,253	$0
2024	48	$20,625,168	$0
2023	43	$20,583,601	$0
2022	39	$18,999,277	$0
2021	35	$18,657,043	$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunity	Number	Agency	Listing	Closes	Award ceiling	Why it matches
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)	PA-24-176	NIH		May 7, 2027	Not listed	Notice number printed on 1 award here
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)	PAR-27-089	NIH	93.395	November 2, 2026	Not listed	Same assistance listing 93.395 as 22 awards here
Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)	PAR-26-152	NIH	93.395	November 11, 2026	Not listed	Same assistance listing 93.395 as 22 awards here
NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)	PAR-27-088	NIH	93.395	November 20, 2026	Not listed	Same assistance listing 93.395 as 22 awards here
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)	PAR-24-214	NIH	93.395	January 7, 2027	$375,000	Same assistance listing 93.395 as 22 awards here
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)	PAR-25-079	NIH	93.395	January 7, 2027	$500,000	Same assistance listing 93.395 as 22 awards here
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)	PAR-25-081	NIH	93.395	January 7, 2027	$499,999	Same assistance listing 93.395 as 22 awards here
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)	RFA-CA-27-005	NIH	93.395	January 11, 2027	$700,000	Same assistance listing 93.395 as 22 awards here
Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)	PAR-27-009	NIH	93.395	January 25, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)	RFA-CA-26-010	NIH	93.395	January 25, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)	RFA-CA-27-003	NIH	93.395	January 25, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)	PA-27-100	NIH	93.395	April 5, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)	PA-27-102	NIH	93.395	April 5, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)	RFA-CA-28-003	NIH	93.395	June 11, 2027	$600,000	Same assistance listing 93.395 as 22 awards here
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)	PA-24-254	NIH	93.395	July 12, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)	PA-24-253	NIH	93.395	July 17, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)	PA-25-080	NIH	93.395	September 7, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)	PAR-24-325	NIH	93.395	September 7, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
Investigator-Focused Award (Parent R35)	PAR-28-037	NIH	93.395	October 4, 2027	Not listed	Same assistance listing 93.395 as 22 awards here
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)	RFA-CA-27-019	NIH	93.395	October 19, 2027	$300,000	Same assistance listing 93.395 as 22 awards here

Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.